TIANSHENG PHARMACEUTICAL GROUP CO., LTD.

Autres langues Tiansheng Pharmaceutical Group Co., Ltd.

Actions

002872

CNE100002QC3

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 20/08/2026			Varia. 5j.	Varia. 1 janv.
5,300 ^CNY	+0,76%		-0,75%	+9,05%

08/05	Tiansheng Pharmaceutical : trois médicaments présélectionnés pour les achats centralisés en Chine	MT
28/04	Tiansheng Pharmaceutical Group Co., Ltd. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

08/05	Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement
28/04	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
28/04	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
12/02	Three Tiansheng Pharma Drugs Set to Win Bids for China's Drug Procurement Program
07/11	Tiansheng pharmaceutical and its controlling shareholder penalised, fined
29/10/25	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
14/10/25	Tiansheng Pharmaceutical Group Subsidiaries Tentatively Win Bulk Drug Tenders in Guangdong
15/09/25	Tiansheng Pharmaceutical Gets China Supplementary Drug Approval for Sodium Bicarbonate Injection
27/08/25	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
28/04/25	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
28/04/25	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
10/02/25	Tiansheng Pharmaceutical Passes Consistency Evaluation for Antibiotic
26/12/24	Chongqing Pharmaceutical Group Changsheng Pharmaceutical Co., Ltd announced that it expects to receive CNY 60 million in funding from C.Q. Pharmaceutical Holding Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd.
29/10/24	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
15/10/24	Tiansheng Pharmaceutical's Isoniazid Tablets Pass Chinese Drug Regulator's Consistency Evaluation
26/08/24	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
25/04/24	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
27/11/23	Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments
17/11/23	Tiansheng Pharmaceutical’s Paracetamol Tablet Passes Consistency Test
27/10/23	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
26/04/23	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
24/02/23	Tiansheng Pharmaceutical's Technology Center Named National Enterprise Technology Center
18/11/22	Tiansheng Pharmaceutical Unit Gets Regulatory Approval for Injection
24/10/22	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
24/08/22	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022